Vnitr Lek 2024, 70(2):E3-E6 | DOI: 10.36290/vnl.2024.027

Cutting-edge technology in medicine: the use of continuous glucose monitoring in reimbursed carein the Czech Republic in 2014-2021: data from the National Registry of Covered Health Services

Jan Brož1, Jana Urbanová2, Martina Nováková3, Klára Benešová4, 5, Jiří Jarkovský4, 5, Ladislav Dušek4, 5, Dominik Foltán1, Matúš Marec1, Lukáš Rozsíval1, Denisa Janíčková Žďárská6, Milan Kvapil3
1 Interní klinika FN Motol a 2. LF UK, Praha
2 Interní klinika FNKV a 3. LF UK, Praha
3 Geriatrická interní klinika 2. LF UK a FN Motol
4 Institut biostatistiky a analýz, LF MU, Brno
5 Ústav zdravotnických informací a statistiky České republiky, Praha
6 Interní klinika 1. LF UK a ÚVN, Praha

Continuous glucose monitoring (CGM) is currently the most effective way to control glucose excursions in patients with diabetes mellitus (DM). In the Czech Republic, health insurance companies have covered enough CGM for patients with type 1 diabetes cover the entire year from December 2019. Based on data obtained from the National Registry of Covered Health Services - NRHZS), an estimated 38% of patients used one of the CGM systems in 2021, with approximately 2/3 of patients using intermittent scan monitoring (isCGM). The analysis showed differences in CGM use between different age groups of diabetic patients and also large differences between regions, with the highest prescribing rate by age falling in the younger age groups and by population in the city of Prague.

Keywords: continuous glucose monitoring, flash glucose monitoring, diabetes mellitus, insurance.

Accepted: April 10, 2024; Published: April 10, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brož J, Urbanová J, Nováková M, Benešová K, Jarkovský J, Dušek L, et al.. Cutting-edge technology in medicine: the use of continuous glucose monitoring in reimbursed carein the Czech Republic in 2014-2021: data from the National Registry of Covered Health Services. Vnitr Lek. 2024;70(2):E3-6. doi: 10.36290/vnl.2024.027.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Brož J, Janíčková Žďárská D, Urbanová ,J et al. Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in the Czech Republic and the Slovak Republic: results of a multinational, multicentre observational survey (DIAINFORM). Diab Therapy. 2018;9(5):1897-1906. Go to original source... Go to PubMed...
    2. Pickup J C, Freeman S C, Sutton A J. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data BMJ. 2011;343:d3805. Go to original source... Go to PubMed...
    3. Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, Longo M, Giugliano D, Esposito K. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2020 May;43(5):1146-1156. Go to original source... Go to PubMed...
    4. Brož J, Anděl M. Možnosti invazivní kontinuální monitorace glykemie: realita a perspektivy. DMEV.6 2003 5:198-204.
    5. Urbanová J, Michalec J, Brož J. Špičkové technologie v medicíně - vliv nastavení hodnot alarmů u systémů pro kontinuální monitoraci glykemie na metabolickou kompenzaci u diabetiků 1. typu: systematické review. Vnitr Lek. 2021;67(6):346-350. doi: 10.36290/vnl.2021.091. Go to original source...
    6. Brož J, Campbell MD, Urbanová J, et al. Characterization of Individualized Glycemic Excursions during a Standardized Bout of Hypoglycemia-Inducing Exercise and Subsequent Hypoglycemia Treatment-A Pilot Study. Nutrients. 2021;13(11):4165. Go to original source... Go to PubMed...
    7. Holubová A, Vlasáková M, Mužík J, Brož J. Customizing the Types of Technologies Used by Patients With Type 1 Diabetes Mellitus for Diabetes Treatment: Case Series on Patient Experience. JMIR Mhealth Uhealth. 2019 Jul 9;7(7):e11527. Go to original source... Go to PubMed...
    8. Templer S. Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions. Front Endocrinol (Lausanne). 2022 Jun 6;13:919942. Go to original source... Go to PubMed...
    9. Di Molfetta S, Caruso I, Cignarelli A, et al. Professional continuous glucose monitoring in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab. 2023 Jan 20. doi: 10.1111/dom.14981. Go to original source... Go to PubMed...
    10. Elbalshy M, Haszard J, Smith H, Kuroko S, Galland B, Oliver N, Shah V, de Bock MI, Wheeler BJ. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials. Diabet Med. 2022 Aug;39(8):e14854. Go to original source... Go to PubMed...
    11. Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022 Apr;65(4):604-619. Go to original source... Go to PubMed...
    12. Blissett DB, Attvall S, Hellmund RA. Analysis Estimating the Potential Cost Impact of Utilizing Flash Glucose Monitoring with Optional Alarms in Swedish Adults with Diabetes with Impaired Awareness of Hypoglycaemia, Using Intensive Insulin. Diabetes Ther. 2021 Aug;12(8):2179-2193. Go to original source... Go to PubMed...
    13. Chaugule S, Oliver N, Klinkenbijl B, Graham C. An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in England. Eur Endocrinol. 2017 Aug;13(2):81-85. Go to original source... Go to PubMed...
    14. Aggarwal A, Pathak S, Goyal R. Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review. Diabetes Res Clin Pract. 2022 Apr;186:109825. Go to original source... Go to PubMed...
    15. Oser TK, Litchman ML, Allen NA, Kwan BM, Fisher L, Jortberg BT, Polonsky WH, Oser SM. Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts. Curr Diab Rep. 2021 Dec 9;21(11):49. Go to original source... Go to PubMed...
    16. Graham C. Continuous Glucose Monitoring and Global Reimbursement: An Update. Diabetes Technol Ther. 2017 Jun;19(S3):S60-S66. doi: 10.1089/dia.2017.0096. Go to original source... Go to PubMed...
    17. Cinek O, Šumník Z. Diabetes mellitus 1. typu: etiologie a epidemiologie. Vnitr Lek. 2019;65(4):235-247. doi: 10.36290/vnl.2019.041 Go to original source...
    18. UZIS. Available from https://www.uzis.cz/sites/default/files/knihovna/nzis_rep_2018_K17_A040_prakticky_lekar_pro_dospele_2017.pdfKvapil M. Diabetologick registr. In Diabetologie 2019, Praha, Triton, 1. vydn, 20
    19. ISBN: 978-80-7553-676-1
    20. Pavlovska I, Polcrova A, Mechanick JI, et al. Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health. Nutrients. 2021;13(7):2338. Go to original source... Go to PubMed...
    21. Gonzalez-Rivas JP, Mechanick JI, Hernandez JP, et al. Prevalence of adiposity-based chronic disease in middle-aged adults from Czech Republic: The Kardiovize study. Obes Sci Pract. 2021;7(5):535-544. Go to original source... Go to PubMed...
    22. Brož J, Malinovská J, Nunes MA, et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25-64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract. 2020 Dec;170:108470. Go to original source... Go to PubMed...
    23. Doporučení České diabetologické společnosti: https://kdp.uzis.cz/res/guideline/pouziti-inzulinove-pumpy-glukozovych-senzoru-u-pacientu-s-diabetem-lecenych-inzulinem-final.pdf

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.